Alethio Therapeutics is a biotech company focused on developing disease-modifying therapies for Myeloproliferative Neoplasms (MPNs), a group of chronic blood cancers
Alethio Therapeutics is a biotech company focused on developing disease-modifying therapies for Myeloproliferative Neoplasms (MPNs), a group of chronic blood cancers. The company leverages its ARTEMIS discovery engine to identify and validate novel therapeutic targets and is advancing multiple antibody-drug conjugate (ADC) programs.